Views and analysis June 24, 2022 New countries stockpile antiviral TPOXX as monkeypox outbreak continues monkeypox, orthopox, Philip Gomez, SIGA technologies, vaccines 0 Comment Share X New countries stockpile antiviral TPOXX as monkeypox outbreak continues https://pharmaphorum.com/r-d/new-countries-stockpile-antiviral-tpoxx-as-monkeypox-outbreak-continues/
Views and analysis June 23, 2022 Spotlight on Women in Science: Giulia Guerrini giulia guerrini, Life Sciences, Medino, STEM, women in science 0 Comment Share X Spotlight on Women in Science: Giulia Guerrini https://pharmaphorum.com/sales-marketing/spotlight-on-women-in-science-giulia-guerrini/
Views and analysis June 22, 2022 US frets over pharma supply chain security biologics, China, fda, pharma, US 0 Comment Share X US frets over pharma supply chain security https://pharmaphorum.com/market-access-2/us-frets-over-pharma-supply-chain-security/
Views and analysis June 21, 2022 IP is no barrier to COVID vaccine access, says industry ABPI, COVID-19, IP frameworks 0 Comment Share X IP is no barrier to COVID vaccine access, says industry https://pharmaphorum.com/market-access-2/ip-is-no-barrier-to-covid-vaccine-access-says-industry/
Views and analysis June 20, 2022 Evaluate’s Orphan Drug Report shows rapid acceleration in the space Andreas Hadjivasiliou, Evaluate, Orphan Drug Report, orphan drugs, Paul Verdin 0 Comment Share X Evaluate’s Orphan Drug Report shows rapid acceleration in the space https://pharmaphorum.com/market-access-2/evaluates-orphan-drug-report-2022/
Views and analysis June 17, 2022 Six months after authorization, what do we know about Paxlovid? COVID-19, fda, Paxlovid, Pfizer 0 Comment Share X Six months after authorization, what do we know about Paxlovid? https://pharmaphorum.com/market-access-2/six-months-after-authorization-what-do-we-know-about-paxlovid/
Views and analysis June 16, 2022 Time is motor neurons – the importance of newborn screening in SMA Deep Dive, Deep Dive: Market Access, market access, Mike Fraser, Novartis Gene Therapies, spinal muscular atrophy 0 Comment Share X Time is motor neurons – the importance of newborn screening in SMA https://pharmaphorum.com/market-access-2/time-is-motor-neurons-the-importance-of-newborn-screening-in-sma/
Views and analysis June 16, 2022 Why diverse clinical trials matter: the pharmaphorum podcast Abbot, clinical trials, Dr. Jennifer Jones-McMeans 0 Comment Share X Why diverse clinical trials matter: the pharmaphorum podcast https://pharmaphorum.com/podcast/why-diverse-clinical-trials-matter/
Views and analysis June 16, 2022 Questions linger as England’s Innovative Medicines Fund kicks off Innovative Medicines Fund, market access, NHS, NICE 0 Comment Share X Questions linger as England’s Innovative Medicines Fund kicks off https://pharmaphorum.com/market-access-2/questions-linger-as-englands-innovative-medicines-fund-kicks-off/
Views and analysis June 15, 2022 England’s Innovative Medicines Fund hits another milestone Department of Health and Social Care, Innovative Medicines Fund, NHS 0 Comment Share X England’s Innovative Medicines Fund hits another milestone https://pharmaphorum.com/market-access-2/englands-innovative-medicines-fund-hits-another-milestone/
Views and analysis June 14, 2022 FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials biologic medicines, China, fda, Lilly 0 Comment Share X FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials https://pharmaphorum.com/market-access-2/fdas-treatment-of-china-developed-drugs-spurs-demands/
Views and analysis June 13, 2022 Appreciating pharmacists’ role in healthcare American Pharmacists Association, APhA, community, PharmD 0 Comment Share X Appreciating pharmacists’ role in healthcare https://pharmaphorum.com/patients/appreciating-pharmacists-role-in-healthcare/
